Gene transfer into human keloid tissue with adeno-associated virus vector

Area of Science:

• Gene therapy
• Dermatology
• Molecular biology

Background:

• Gene transfer offers novel therapeutic strategies for intractable disorders.
• Adeno-associated virus (AAV) vectors have shown successful transfection in various human tissues, including skin.
• Keloids represent a fibrotic skin condition with limited treatment options.

Purpose of the Study:

• To evaluate the efficacy of AAV vector-mediated gene transfer and expression in human keloid tissue.
• To assess the potential of AAV vectors as a delivery system for therapeutic genes in keloid treatment.

Main Methods:

• Human keloid specimens were obtained and injected with an AAV vector encoding the beta-galactosidase reporter gene.
• Tissue samples were incubated for four weeks post-injection.
• Gene expression was analyzed using reverse-transcriptase polymerase chain reaction (RT-PCR) for mRNA detection and X-gal staining for enzymatic activity.

Main Results:

• RT-PCR confirmed the presence of reporter gene mRNA in keloid tissue four weeks after AAV vector injection.
• Positive X-gal staining indicated successful beta-galactosidase enzymatic activity, confirming gene expression.
• These findings demonstrate effective transduction of human keloid tissue by the AAV vector.

Conclusions:

• Adeno-associated virus (AAV) vectors can effectively transduce human keloid tissue.
• The successful reporter gene expression suggests feasibility for replacing it with therapeutic genes.
• AAV-mediated gene therapy holds potential for future keloid treatment strategies.